Beyond Weight Loss: the Diverse Benefits of GLP-1s

While GLP-1 medications continue to make headlines for their highly effective weight loss results, emerging research links them with other health benefits, too.

‍

‍

How do GLP-1 medications work?

There’s been a lot of attention in the media about new obesity drugs because they can support remarkable weight loss results.

Semaglutide medications like Ozempic and related medications like Zepbound are in the GLP-1 class of drugs, which mimic the action of a hormone called glucagon-like peptide-1. This medication acts on several systems to decrease appetite by producing feelings of fullness. It affects the appetite centers of the brain and slows down how quickly the stomach empties, which leaves you feeling full for longer. Semaglutide also acts on the pancreas to increase insulin secretion and decrease glucagon. (This reduces blood sugar levels, after you eat.) Another way semaglutide works is converting white fat-storing cells into brown fat, which increases energy expenditure.

GLP-1s and heart disease

Beyond GLP-1s’ well-known role in weight management and diabetes care, these medications are garnering attention for their potential to reduce the risk of heart disease. But how exactly do GLP-1 medications work their magic when it comes to heart health?

The GLP-1 hormone not only helps to control blood sugar but also can have direct positive impacts on blood vessels and heart function, ultimately reducing the risk of heart disease. Studies and research have consistently supported the cardiovascular benefits of GLP-1 medications. Research published in reputable journals has shown that patients using GLP-1 medications experience lower rates of heart attacks, strokes, and other cardiovascular events compared to those on other diabetes medications or placebo. These findings are significant because they highlight the potential of GLP-1 medications not just in managing diabetes and supporting weight loss but also in protecting against one of the leading causes of mortality worldwide – heart disease.

For patients, the implications are profound. If you're managing diabetes or at risk of heart disease, discussing GLP-1 medications with your healthcare provider could be a game-changer. These medications offer a dual benefit of controlling blood sugar and providing cardiovascular protection, potentially leading to better long-term health outcomes. As research continues to unfold, we can expect more insights into the specific mechanisms behind GLP-1 medications' heart-protective effects and even more tailored approaches to managing heart health in patients with diabetes.

Looking ahead, the next steps in research will likely delve deeper into understanding how GLP-1 medications interact with different heart disease risk factors, optimizing treatment strategies, and exploring potential synergies with other therapies.

‍GLP-1s and kidneys

GLP-1 medications act by targeting specific receptors in the kidneys, known as GLP-1 receptors. When these receptors are activated, they initiate a series of beneficial responses within the kidneys. One key effect is the reduction of inflammation and oxidative stress, which are common culprits in kidney damage and disease progression. By calming down these harmful processes, GLP-1 medications help maintain the structural integrity of the kidneys and preserve their function over time.

This kidney-protective action of GLP-1 medications holds immense importance, especially for individuals with conditions like diabetes. Diabetes is a leading cause of kidney disease, known as diabetic nephropathy, which can ultimately lead to kidney failure if left unchecked. By incorporating GLP-1 medications into diabetes management plans, healthcare providers can not only help control blood sugar levels but also proactively safeguard kidney health. This dual benefit not only enhances overall well-being but also reduces the risk of complications associated with advanced kidney disease. In essence, the kidney-protective effects of GLP-1 medications underscore their holistic approach to managing diabetes and promoting long-term health outcomes for patients. One early study suggests that GLP-1s had a 24% risk reduction in kidney- and cardiovascular-related mortality.

Diabetes is the leading cause of kidney disease, and many people with diabetes also develop high blood pressure, which can damage kidneys too. Given the interconnectedness of these conditions, it’s exciting that GLP-1 medications can potentially positively impact all three.

‍GLP-1s and PCOS (Polycystic Ovary Syndrome)

GLP-1s influence the hormones related to appetite and feelings of fullness–and these hormones play a role in other health conditions, too.

Why does this all matter? Well, hormonal imbalances and metabolic issues are at the root of many health challenges faced by many people. From PCOS and insulin resistance to obesity and metabolic syndrome, these conditions can significantly impact quality of life and increase the risk of serious health complications like diabetes and cardiovascular disease.

PCOS affects 8-13% of women of reproductive age, and involves many symptoms. It’s the most common cause of infertility, yet it’s estimated that 70% of affected women aren’t diagnosed. Symptoms of PCOS include irregular periods, weight gain, excess body hair, thinning hair, and darker patches of skin. The relationship between weight gain and PCOS isn’t quite understood, but many people with PCOS have insulin resistance and are at a higher risk of developing type 2 diabetes. While GLP-1s aren’t approved to treat PCOS, studies are looking at how GLP-1s may influence the menstrual cycle and other hormonal disruptions that are associated with PCOS.

By using GLP-1 medications to address these underlying issues, healthcare providers can offer patients a more comprehensive approach to health management. This not only improves symptoms and outcomes but also empowers individuals to take proactive steps towards long-term well-being. In essence, the role of GLP-1s in managing hormonal imbalances and metabolic issues isn't just a side note—it's a potential game-changer.

‍GLP-1s and menstrual and reproductive health

Another area where GLP-1s are making waves: their impact on menstrual cycles and fertility. While these medications are renowned for their metabolic benefits, emerging research suggests they might also play a role in supporting reproductive health in women. Although the exact mechanisms are still being studied, it's believed that GLP-1s could influence hormone levels and ovarian function, leading to more balanced menstrual cycles and enhanced fertility. These findings open up intriguing possibilities for using GLP-1s as part of a holistic approach to addressing reproductive health concerns in women.

For women's health providers, this offers valuable considerations when evaluating and managing patients with menstrual irregularities or fertility issues. Incorporating discussions about GLP-1 medications into clinical assessments can provide a broader perspective on treatment options and empower patients with knowledge about potential benefits beyond metabolic health. As research continues to shed light on the intricate interplay between GLP-1s and reproductive biology, women's health practitioners are poised to leverage this knowledge for more personalized and effective care strategies.

GLP-1s and Parkinson's

A recent small study has suggested that a medication similar to the blockbuster weight-loss drugs could potentially slow the progression of Parkinson’s disease. The drug tested is called lixisenatide, which is a GLP-1 receptor agonist made by Sanofi in the same category as Ozempic and Wegovy. The study followed 156 people with early Parkinson’s who were randomly assigned either lixisenatide or a placebo. Parkinson’s symptoms (such as tremor, stiffness, slowness, and balance issues) worsened in those taking the placebo while symptoms did not worse in those taking the drug. Studies have shown that people with type 2 diabetes and insulin resistance are at an increased risk for Parkinson's disease  which GLP-1s address. Experts consider these findings a promising starting point for future research on GLP-1s effects against neuroligal disorders, but they also caution that this is very early research and requires larger and longer studies.

In summary, GLP-1 medications potentially offer a lot more than just weight loss benefits—they may indeed be versatile tools for our health toolkit. They might help protect our hearts, maintain kidney health, ease symptoms of conditions like PCOS and Parkinson's, and might even support menstrual cycles, reproductive health, and fertility. As we learn more through research, it's clear that GLP-1s have a lot to offer in promoting our overall well-being.

‍About Hello Alpha

Hello Alpha is comprehensive virtual primary care for women. With a personalized approach catering to an individual’s unique health goals, Hello Alpha can treat more than 100 conditions ranging from allergies to eczema and diabetes to menopause. Additionally, Alpha providers will proactively help identify and manage underdiagnosed conditions while connecting patients to labs, specialists, and other essential resources. The aim is to ensure that patients feel as healthy and vibrant as possible.

You can start a visit right now.

PLEASE NOTE:  THIS BLOG DOES NOT PROVIDE MEDICAL ADVICE.

The information, including but not limited to, text, graphics, images and other material contained on this website are for informational/educational purposes only.  No material on this site is intended to substitute for professional medical advice, diagnosis or treatment. A patient-client relationship will only be formed after you enter into a written agreement with an Alpha provider. Always consult a professional in the area for your particular needs before undertaking any new healthcare regimen.

‍